顺铂耐药卵巢癌的差异表达基因和信号通路富集分析
Analysis of Differential Expression Genes and Signal Pathways Associated with Cisplatin Resistant Ovarian Cancer
-
摘要: 目的 分析顺铂耐药卵巢癌的差异表达基因和信号通路.方法 用美国国立信息中心NCBI的GEO数据库获得顺铂耐药卵巢癌基因集GSE15372, 通过R与Bioconductor软件进行差异表达基因分析;再利用DAVID在线工具对顺铂耐药卵巢癌差异表达基因进行GO本体分析、KEGG通路分析.结果 差异倍数在2倍以上、FDR值小于0.05为标准, 筛选出上调差异表达基因和下调差异表达基因获得差异表达基因211个, 其中上调基因120个, 下调基因91个;基因富集分析发现差异表达基因集中在黏着斑、TGF-β信号通路等生物过程 (P<0.05) .结论 顺铂耐药卵巢癌存在一些特异的差异表达基因, 有部分信号通路在顺铂耐药卵巢癌中明显富集.Abstract: Objective To analyze the differentially expressed genes and signaling pathways in cisplatin resistant ovarian cancer. Me thods Cisplatin resistant ovarian cancer gene set GSE15372 was obtained from the GEO database of the national information center of the United States. The Differential expression gene analysis was performed by R and Bioconductor software, the GO and KEGG pathway of the differentially expressed genes were analyzed by DAVID online tool. Results 211 differentially expressed genes were obtained, including 120 up-and91 down-regulated genes as the standa rd was set that fold change was more than 2 times and FDR was less than0.05. Gene enrichment analysis of differentially expressed genes found in focal adhesion, TGF-beta signaling pathways and other biological processes (P<0.05) . Conclus ion There are some specific differentially expressed genes in the cisplatin resistant ovarian cancer, partial signal pathways were obvious enrichment in the cisplatin resistant ovarian cancer.
-
[1] [1]SIEGEL R, MA J, ZOU Z, et al.Cancer statistics[J].CA Cancer J Clin, 2014, 64 (1) :9-29. [2] [2]DASARI S.Tchounwou PB2.Cisplatin in cancer therapy:molecular mechanisms of action[J].Eur J Pharmacol, 2014, 5 (74) :364-378. [3] [3]LIU X, GAO Y, LU Y, et al.Oncogenes associated with drug resistance in ovarian cancer[J].Cancer Res Clin Oncol.2014, 10 (5) :1432-1435. [4] [4]TANYA BARRETT, DENNIS B, TROUP, STEPHEN E, et al.NCBI GEO:archive for high-throughput functional genomic data[J].Nucleic Acids Research, 2009, 37 (Databae issue) :885-890. [5] [5]SHERMAN B T, HUANG DA W, TAN Q, et al.DAVID Knowledgebase:a gene-centered database integrating heterogeneous gene annotation resources to facilitate high-throughput gene functional analysis[J].BMC Bioinformatics, 2007, 2 (8) :42. [6] [6]LI M, BALCH C, MONTGOMERY J S, et al.Integrated analysis of DNA methylation and gene expression reveals specific signaling pathways associated with platinum resistance in ovarian cancer[J].BMC Med Genomics, 2009, 8 (2) :34. [7] [7]SUBRAMANIAN A, KUEHN H, GOULD J, et al.GSEA-P:a desktop application for gene set enrichment analysis[J].Bioinformatics, 2007, 23 (23) :3251-3253. [8] [8]TAKAHASHI M, SUNG B, SHEN Y, et al.Boswellic acid exerts antitumor effects in colorectal cancer cells by modulating expression of the let-7 and mi R-200 micro RNA family[J].Carcinogenesis, 2012, 33 (12) :2441-2449. [9] [9]HUANG D, KHOE M, BEFEKADU M, et al.Focal adhesion kinase mediates cell survival via NF-kappa B and ERK signaling pathways[J].Am J Physiol Cell Physiol, 2007, 92 (4) :1339-1352. [10] [10]PARK H, HAN I, KWON H J, et al.Focal adhesion kinase regulates syndecan-2-mediated tumorigenic activity of HT1080 fibrosarcoma cells[J].Cancer Res, 2005, 65 (21) :9899-9905. [11] [11]MZLEAN G W, CARRAGHER N O, AVIZIENYTE E, et al.The role of focal-adhesion kinase in cancer.A new therapeutic opportunity[J].Nature Rev Cancer, 2005, 5 (7) :505. [12] [12]LONN P, MOREN A, RAJA E, et al.Regulating the stability of TGFbeta receptors and Smads[J].Cell Res, 2009, 19 (6) :21-35. [13] [13]PICKUP M, NOVITSKIY S, MOSES H L.The roles of TGFβin the tumour microenvironment[J].Nat Rev Cancer, 2013, 13 (5) :788-799. [14] [14]CHENFENGCHEN, KONG-NANZHAO, PAULP.MASC I, et al.TGFβisoforms and receptors m RNA expression in breast tumours:prognostic value and clinical implications[J].BMC Cancer, 2015, 15:1010-1012. [15] [15]JAY PILROSE, PHILLIP, WUL FRIDGE, et al.Decitabine reactivated pathways in platinum resistant ovarian cancer[J].Oncotarget, 2014, 5 (11) :3579-3589.
点击查看大图
计量
- 文章访问数: 3154
- HTML全文浏览量: 1222
- PDF下载量: 275
- 被引次数: 0